SCHEMBL22196775

SCHEMBL22196775

CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N(C)CC

nearest known ligand 0.88

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 20/20 0.88
▸ FGFR3 P22607 10/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15043296 0.94 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15023073 0.90 FGFR1 (0.88) FGFR1FGFR3
SCHEMBL15043290 0.90 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043291 0.88 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043292 0.87 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043301 0.85 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043297 0.85 FGFR1 (0.79) FGFR1FGFR3
SCHEMBL15043289 0.85 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043303 0.84 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15046136 0.84 FGFR1 (1.00) FGFR1FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3268490-B1 SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS Bayer Pharma AG (DE) 2020-07-08 — — EP disclosed
Send feedback